Zhikai Zheng

4PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 07, 2024
Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study.

Zhikai Zheng, Jiongliang Wang, Tianqing Wu

|Mar 11, 2024
Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.

Wenxuan Li, Zhikai Zheng, Jiongliang Wang

|Dec 07, 2023
Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy.

Tianqing Wu, Zhikai Zheng, Jiongliang Wang

|Dec 06, 2023
Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy.

Zhikai Zheng, Jiongliang Wang, Tianqing Wu

Pageof 1

Frequent Collaborators

3 joint publications

Tianqing Wu

3 joint publications

Yangxun Pan

3 joint publications

Jinbin Chen

3 joint publications

Li Xu